H. B. Ragnum

The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer

H. Lyng, T. Seierstad, A. Lie, 2014, British Journal of Cancer.

A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients

H. Lyng, T. Seierstad, L. Vlatkovic, 2022, British Journal of Cancer.

Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients.

H. Lyng, S. Patzke, T. Seierstad, 2018, Cancer research.

A man in his sixties with dyspnoea following immunotherapy.

M. Nyakas, K. Nilsen, H. B. Ragnum, 2021, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer

D. Olsen, L. Vlatkovic, A. Ree, 2013, PloS one.

Hypoxia in prostate cancer: Gene expression profiling in relation to disease aggressiveness and treatment interventions

H. B. Ragnum, Harald Bull Ragnum, 2014 .

Comparison of time curves from dynamic 18F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas

T. Seierstad, A. Lie, L. Vlatkovic, 2018, Physics and imaging in radiation oncology.

Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition

T. Stokke, H. Lyng, T. Clancy, 2016, British Journal of Cancer.

Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer.

J. Nesland, H. Lyng, R. Holm, 2013, International journal of radiation oncology, biology, physics.

Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients.

H. Lyng, S. Patzke, T. Seierstad, 2018, Cancer research.